NeoGenomics (NEO) shares ended the last trading session 9.1% higher at $13.78. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

On Monday, NeoGenomics, Inc. (NEO) stock saw a decline, ending the day at $12.63 which represents a decrease of $-2.14 or -14.49% from the prior close of $14.77. The stock opened at $14.11 and touched ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on NeoGenomics (NEO – Research Report). The company’s shares ...

The put/call ratio of NEO is 0.21, indicating a bullish outlook ... Additionally, our exclusive stock picks are powered by ...

NeoGenomics (NEO – Research Report) received a Hold rating and price target from Benchmark Co. analyst Bruce Jackson today. The company’s ...

Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.

NeoGenomics (NASDAQ:NEO – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a note issued to investors on Friday,Benzinga reports. They ...

In the last twelve months Neo Performance Materials insiders were buying shares, but not selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the ...

For further insights into TSE:NEO stock, check out TipRanks’ Stock Analysis page. TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award ...

NeoGenomics (NEO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. FT.